* 南京维立志博生物科技股份有限公司9887.HK周五香港首日挂牌开高107%后，盘中一度扩大涨幅至127%，触及79.6港元。
* 这家专注于肿瘤及自身免疫性疾病疗法的公司此前以招股价区间顶端的每股35港元定价，香港首次公开发售（IPO）集资12.9亿港元，公开发售及国际配售分别获近3,494倍及40倍超额认购。
* 香港股市恒生指数.HSI盘中跌0.5%，恒生生物科技指数.HSHKBIO涨0.7%。（完）
更多股市简讯请点选CN-CMN-HOT
(记者 雷美珍；审校 杨淑祯)
((alison.lui@thomsonreuters.com; +852 3462 7749;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.